Fact CheckerSign in

NCT05755490Completed

PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention

Source: ClinicalTrials.gov · Last updated 2 Oct 2025

Brief summary (registry, in English)

The goal of this research study is to conduct an open pilot of a behavioral change intervention called PROstate Cancer Wearables, Exercise, and Structured Supports (PROWESS) for integrating health behavior change tools and to increase exercise, reduce side effects of androgen deprivation therapy (ADT), and improve quality of life in Black and Hispanic/Latino men with prostate cancer. The name of the intervention used in this research study is: PROWESS (behavioral change intervention)

Status (registry)
Completed
Study type
Interventional
Enrollment
14 (actual)
First submitted
13 Feb 2023
Start date
28 Aug 2023
Primary completion date
2 Dec 2024
Lead sponsor
Massachusetts General Hospital
NCT number
NCT05755490

What you commit to

  • Study type: Interventional
  • Participants enrolled: 14
  • From 28 Aug 2023 to the primary completion date, 2 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently receiving chemotherapy.

Other illness

  • Significant psychiatric, cognitive or other comorbid disease which the treating clinician believes prohibits informed consent or participation in the study.

Other

  • Unwilling or unable to participate in the study.
  • Prognosis less than 6 months, per the judgment of the primary oncologist.
  • Medical contraindication to physical activity, as assessed by outpatient oncologist.

Who the study is looking for

  • Diagnosed with prostate cancer.
  • Planning to be on androgen deprivation therapy (ADT) for at least three months
  • Black Race AND/OR Hispanic/Latino Ethnicity (confirmed by patient self-report)
  • Verbal fluency in English or Spanish.
  • Receiving ongoing oncology care at MGH Cancer Center.
  • Age ≥ 18 years.
  • Self-Report less than or equal to 150 minutes of moderate or vigorous structured exercise per week, as assessed by the Exercise is Medicine Physical Activity Vital Sign Assessment
  • Completion of baseline assessment

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital Cancer Center
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.